Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed250%
terminated250%

Recent Activity

0 active trials
Showing 4 of 4
terminated

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

NCT04292405
completed

Heart Failure Optimization Study

NCT03016754
completed

LifeVest Safety and Efficacy in Real Life Settings in France

NCT03319160
terminatednot_applicable

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

NCT02481206

Clinical Trials (4)

Showing 4 of 4 trials
NCT04292405

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

Terminated
NCT03016754

Heart Failure Optimization Study

Completed
NCT03319160

LifeVest Safety and Efficacy in Real Life Settings in France

Completed
NCT02481206Not Applicable

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4